B. Riley Wealth Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,727
| Closed | -$1.66M | – | 926 |
|
|
2019
Q3 | $1.66M | Sell |
16,727
-16
| -0.1% | -$1.52K | 0.16% | 140 |
|
|
2019
Q2 | $1.55M | Buy |
16,743
+254
| +2% | +$24.1K | 0.17% | 126 |
|
|
2019
Q1 | $1.56M | Sell |
16,489
-13,074
| -44% | -$1.14M | 0.19% | 108 |
|
|
2018
Q4 | $1.9M | Sell |
29,563
-207
| -0.7% | -$15.3K | 0.27% | 83 |
|
|
2018
Q3 | $2.67M | Buy |
29,770
+293
| +1% | +$25.9K | 0.32% | 66 |
|
|
2018
Q2 | $2.34M | Sell |
29,477
-700
| -2% | -$58.1K | 0.31% | 69 |
|
|
2018
Q1 | $2.69M | Buy |
30,177
+3,892
| +15% | +$374K | 0.38% | 65 |
|
|
2017
Q4 | $2.74M | Buy |
26,285
+6,838
| +35% | +$772K | 0.37% | 68 |
|
|
2017
Q3 | $2.84M | Buy |
19,447
+332
| +2% | +$45.2K | 0.47% | 47 |
|
|
2017
Q2 | $2.48M | Buy |
19,115
+3,549
| +23% | +$435K | 0.45% | 53 |
|
|
2017
Q1 | $1.94M | Buy |
15,566
+656
| +4% | +$78.5K | 0.39% | 64 |
|
|
2016
Q4 | $1.73M | Sell |
14,910
-4,401
| -23% | -$490K | 0.35% | 77 |
|
|
2016
Q3 | $1.59M | Sell |
19,311
-2,038
| -10% | -$221K | 0.31% | 77 |
|
|
2016
Q2 | $1.7M | Buy |
21,349
+3,558
| +20% | +$368K | 0.34% | 61 |
|
|
2016
Q1 | $1.37M | Sell |
17,791
-581
| -3% | -$59.8K | 0.32% | 79 |
|
|
2015
Q4 | $2.2M | Buy |
18,372
+5,214
| +40% | +$603K | 0.45% | 53 |
|
|
2015
Q3 | $1.42M | Sell |
13,158
-1,559
| -11% | -$193K | 0.34% | 67 |
|
|
2015
Q2 | $1.71M | Sell |
14,717
-50
| -0.3% | -$5.72K | 0.42% | 52 |
|
|
2015
Q1 | $1.7M | Buy |
14,767
+1,926
| +15% | +$230K | 0.41% | 54 |
|
|
2014
Q4 | $9.51K | Buy |
12,841
+4,645
| +57% | +$490K | 0.2% | 105 |
|
|
2014
Q3 | $777K | Sell |
8,196
-10,940
| -57% | -$987K | 0.2% | 133 |
|
|
2014
Q2 | $800K | Buy |
19,136
+11,370
| +146% | +$865K | 0.19% | 117 |
|
|
2014
Q1 | $542K | Buy |
7,766
+3,202
| +70% | +$254K | 0.16% | 141 |
|
|
2013
Q4 | $386K | Buy |
4,564
+126
| +3% | +$9.97K | 0.12% | 188 |
|
|
2013
Q3 | $342K | Buy |
4,438
+230
| +5% | +$16.1K | 0.12% | 200 |
|
|
2013
Q2 | $246K | Buy |
+4,208
| New | +$253K | 0.08% | 273 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
B. Riley Wealth Advisors's CELG Position: Q4 2019 in Review
B. Riley Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 16,727 shares — an estimated $1.66M sold.
B. Riley Wealth Advisors first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.84M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- B. Riley Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- B. Riley Wealth Advisors sold 16,727 Celgene Corp shares in Q4 2019, an estimated $1.66M.
- B. Riley Wealth Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- B. Riley Wealth Advisors's Celgene Corp position peaked at $2.84M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on B. Riley Wealth Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.